SOCRA CCRP ACTUAL EXAM CLOSING SCRIPT UPDATED QUESTIONS AND ANSWERS VIEW AHEAD PREP MATERIAL SOLVED

SOCRA CCRP ACTUAL EXAM CLOSING
SCRIPT UPDATED QUESTIONS AND
ANSWERS VIEW AHEAD PREP MATERIAL
SOLVED

⩥ IND.
Answer: Investigational New Drug regulatory pathway for clinical
studies


⩥ IDE.
Answer: Investigational Device Exemption regulatory pathway for
clinical studies


⩥ Informed Consent.
Answer: Process including development, content, and approval for
subjects


⩥ Financial Disclosure.
Answer: Requirement for reporting financial interests of clinical
investigators


⩥ Investigator's Brochure.

,Answer: Document providing information on investigational product


⩥ Significant Risk Determination.
Answer: Assessment of risks associated with investigational products


⩥ Essential Documents.
Answer: Required paperwork for clinical studies, including informed
consent


⩥ Delegation of Duties.
Answer: Assignment of responsibilities among study team members


⩥ FDA Form 1572.
Answer: Document for clinical investigators to provide information to
the FDA


⩥ IRB/IEC.
Answer: Institutional Review Board/Independent Ethics Committee


⩥ GCP.
Answer: Good Clinical Practice guidelines for conducting clinical
studies

, ⩥ Compliance.
Answer: Adherence to laws and regulations in conducting research
studies


⩥ Site Evaluation.
Answer: Assessment of clinical sites for study suitability


⩥ Training.
Answer: Educating study staff on protocol, GCP, and investigational
product


⩥ SOP.
Answer: Standard Operating Procedure for IRB/IEC processes


⩥ IRB/IEC Membership Requirements.
Answer: Criteria individuals must meet to be part of the review board


⩥ IRB/IEC Protocol Review Requirements.
Answer: Specifications for reviewing research study protocols


⩥ IRB/IEC Protocol Amendment Review Requirements.
Answer: Guidelines for reviewing amendments to research protocols